Margaret, a 39-
What is schizophrenia?
Schizophrenia is a psychotic disorder (psychosis is a break from reality) characterized by the profound disruption of basic psychological processes; a distorted perception of reality; altered or blunted emotion; and disturbances in thought, motivation, and behavior. Traditionally, schizophrenia was regarded primarily as a disturbance of thought and perception, in which the sense of reality becomes severely distorted and confused. However, this condition is now understood to take different forms affecting a wide range of functions. According to the DSM–5, schizophrenia is diagnosed when two or more symptoms emerge during a continuous period of at least 1 month with signs of the disorder persisting for at least 6 months. The symptoms of schizophrenia often are separated into positive, negative, and cognitive symptoms.
608
Positive symptoms of schizophrenia include thoughts and behaviors not seen in those without the disorder, such as
609
Negative symptoms are deficits or disruptions to normal emotions and behaviors. They include emotional and social withdrawal; apathy; poverty of speech; and other indications of the absence or insufficiency of normal behavior, motivation, and emotion. These symptoms refer to things missing in people with schizophrenia. Negative symptoms may rob people of emotion, for example, leaving them with flat, deadpan responses; their interest in people or events may be undermined, or their capacity to focus attention may be impaired.
Cognitive symptoms are deficits in cognitive abilities, specifically in executive functioning, attention, and working memory. These are the most difficult symptoms to notice because they are much less bizarre and public than the positive and negative symptoms. However, these cognitive deficits often play a large role in terms of preventing people with schizophrenia from achieving a high level of functioning, such as maintaining friendships and holding down a job (Green et al., 2000).
Schizophrenia occurs in about 1% of the population (Jablensky, 1997) and is slightly more common in men than in women (McGrath et al., 2008). Early versions of the DSM suggested that schizophrenia might have a very early onset—
In 1899, when German psychiatrist Emil Kraepelin first described the syndrome we now know as schizophrenia, he remarked that the disorder was so severe that it suggested “organic,” or biological, origins. Over the years, accumulating evidence for the role of biology in schizophrenia has come from studies of genetic factors, biochemical factors, and neuroanatomy.
Family studies indicate that the closer a person’s genetic relatedness to a person with schizophrenia, the greater the likelihood of developing the disorder (Gottesman, 1991). As shown in FIGURE 15.4, concordance rates increase dramatically with biological relatedness. The rates are estimates and vary considerably from study to study, but almost every study finds the average concordance rates higher for identical twins (48%) than for fraternal twins (17%), which suggests a genetic component for the disorder (Torrey et al., 1994).
What is the role of genetics in schizophrenia?
610
Although genetics clearly have a strong predisposing role in schizophrenia, considerable evidence suggests that environmental factors, such as the prenatal and perinatal environments, also affect concordance rates (Jurewicz, Owen, & O’Donovan, 2001; Thaker, 2002; Torrey et al., 1994). For example, because approximately 70% of identical twins share the same prenatal blood supply, toxins in the mother’s blood could contribute to the high concordance rate. More recent studies (discussed in the earlier section on bipolar disorder) are contributing to a better understanding of how environmental stressors can trigger epigenetic changes that increase susceptibility to this disorder.
During the 1950s, major tranquilizers were discovered that could reduce the symptoms of schizophrenia by lowering levels of the neurotransmitter dopamine. The effectiveness of many drugs in alleviating schizophrenic symptoms is related to the drugs’ capacity to reduce dopamine’s role in neurotransmission in certain brain tracts. This finding suggested the dopamine hypothesis, the idea that schizophrenia involves an excess of dopamine activity. The hypothesis has been invoked to explain why amphetamines, which increase dopamine levels, often exacerbate symptoms of schizophrenia (Iverson, 2006).
If only things were so simple. Considerable evidence suggests that this hypothesis is inadequate (Moncrieff, 2009). For example, many individuals with schizophrenia do not respond favorably to dopamine-
611
When neuroimaging techniques became available, researchers immediately started looking for distinctive anatomical features of the brain in individuals with schizophrenia. The earliest observations revealed enlargement of the ventricles, hollow areas filled with cerebrospinal fluid, lying deep within the core of the brain (see FIGURE 15.5; Johnstone et al., 1976). In some individuals (primarily those with chronic, negative symptoms), the ventricles were abnormally enlarged, suggesting a loss of brain tissue mass that could arise from an anomaly in prenatal development (Arnold et al., 1998; Heaton et al., 1994).
How are the brains of people with schizophrenia different from those without this disorder?
Understanding the significance of this brain abnormality for schizophrenia is complicated by several factors, however. First, such enlarged ventricles are found in only a minority of cases of schizophrenia. Second, some individuals who do not have schizophrenia also show evidence of enlarged ventricles. Finally, this type of brain abnormality can be caused by the long-
Neuroimaging studies provide evidence of a variety of brain abnormalities in schizophrenia. Paul Thompson and his colleagues (2001) examined changes in the brains of adolescents whose MRI scans could be traced sequentially from the onset of schizophrenia. By morphing the images onto a standardized brain, the researchers were able to detect progressive tissue loss beginning in the parietal lobe and eventually encompassing much of the brain (see FIGURE 15.6). All adolescents lose some gray matter over time in a kind of normal “pruning” of the brain, but in the case of those developing schizophrenia, the loss was dramatic enough to seem pathological. A variety of specific brain changes found in other studies suggests a clear relationship between biological changes in the brain and the progression of schizophrenia (Shenton et al., 2001).
With all these potential biological contributors to schizophrenia, you might think there would be few psychological or social causes of the disorder. However, several studies do suggest that the family environment plays a role in the development of and recovery from the condition. One large-
612
613
This chapter describes what we know about the characteristics and causes of mental disorders, and the next chapter describes how these disorders are commonly treated. For some of the more severe disorders, such as schizophrenia, the picture does not look good. People diagnosed with schizophrenia often are informed that it is a lifelong condition, and although current treatments show some effectiveness in decreasing the delusional thinking and hallucinations often present in those with schizophrenia, people with this disorder often are unable to hold down a full-
Elyn Saks is one such person who received a diagnosis of schizophrenia and was informed of this prognosis. She described what happened next in a longer version of the following article that appeared in the New York Times (2013).
Thirty years ago, I was given a diagnosis of schizophrenia. My prognosis was “grave”: I would never live independently, hold a job, find a loving partner, get married. My home would be a board-
Then I made a decision. I would write the narrative of my life. Today I am a chaired professor at the University of Southern California Gould School of Law. I have an adjunct appointment in the department of psychiatry at the medical school of the University of California, San Diego. The MacArthur Foundation gave me a genius grant.
Although I fought my diagnosis for many years, I came to accept that I have schizophrenia and will be in treatment the rest of my life…. What I refused to accept was my prognosis.
Conventional psychiatric thinking and its diagnostic categories say that people like me don’t exist. Either I don’t have schizophrenia (please tell that to the delusions crowding my mind), or I couldn’t have accomplished what I have (please tell that to U.S.C.’s committee on faculty affairs). But I do, and I have. And I have undertaken research with colleagues at U.S.C. and U.C.L.A. to show that I am not alone. There are others with schizophrenia and such active symptoms as delusions and hallucinations who have significant academic and professional achievements.
Over the last few years, my colleagues…and I have gathered 20 research subjects with high-
How had these people with schizophrenia managed to succeed in their studies and at such high-
Other techniques that our participants cited included controlling sensory inputs. For some, this meant keeping their living space simple (bare walls, no TV, only quiet music), while for others, it meant distracting music. “I’ll listen to loud music if I don’t want to hear things,” said a participant who is a certified nurse’s assistant. Still others mentioned exercise, a healthy diet, avoiding alcohol and getting enough sleep….
One of the most frequently mentioned techniques that helped our research participants manage their symptoms was work. “Work has been an important part of who I am,” said an educator in our group. “When you become useful to an organization and feel respected in that organization, there’s a certain value in belonging there.” This person works on the weekends too because of “the distraction factor.” In other words, by engaging in work, the crazy stuff often recedes to the sidelines….
THAT is why it is so distressing when doctors tell their patients not to expect or pursue fulfilling careers. Far too often, the conventional psychiatric approach to mental illness is to see clusters of symptoms that characterize people. Accordingly, many psychiatrists hold the view that treating symptoms with medication is treating mental illness. But this fails to take into account individuals’ strengths and capabilities, leading mental health professionals to underestimate what their patients can hope to achieve in the world….A recent New York Times Magazine article described a new company that hires high-
An approach that looks for individual strengths, in addition to considering symptoms, could help dispel the pessimism surrounding mental illness. Finding “the wellness within the illness,” as one person with schizophrenia said, should be a therapeutic goal. Doctors should urge their patients to develop relationships and engage in meaningful work. They should encourage patients to find their own repertory of techniques to manage their symptoms and aim for a quality of life as they define it. And they should provide patients with the resources—
Elyn Saks’s story is amazing and inspiring. It also is quite unusual. How should we incorporate stories like hers and the people in the research study she described? Are these people outliers—
From the New York Times, January 25, 2013. © 2013 The New York Times. All rights reserved. Used by permission and protected by the Copyright Laws of the United States. The printing, copying, redistribution, or retransmission of this Content without express written permission is prohibited. http:/
614